Using a detailed proteomics analysis of the mutant ALK signaling components in NB, the signaling adaptor protein ‘insulin receptor substrate 2′ (IRS2) was also identified as a major ALK downstream target further controlling the PI3K/AKT/FOXO3a axis [132]. The gene discussed is ALK; the disease is neuroblastoma.